AUG 4, 2026 · PHASE 1 TRIAL
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
ClinicalTrials.gov
Clinical trial registry record for terminated Phase 1 study with no results reported; preliminary status reflects early-stage investigation without outcome data.
Reported
Study phasePHASE 1
Actual enrollment8
Primary outcome measure 1Rate of dose limiting toxicities (DLTs) in…